Select Medical Holdings SEM Accounts Receivable, Credit Loss Expense (Reversal)
Accounts Receivable, Credit Loss Expense (Reversal) at other companies
Other financials
Where this comes from
Reported directly by Select Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Select Medical Holdings's accounts receivable, credit loss expense (reversal).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Select Medical Holdings's accounts receivable, credit loss expense (reversal)?
- Select Medical Holdings (SEM) reported accounts receivable, credit loss expense (reversal) of $1.1M in Q1 2026.
- How has Select Medical Holdings's accounts receivable, credit loss expense (reversal) changed year-over-year?
- Select Medical Holdings's accounts receivable, credit loss expense (reversal) decreased by 51.9% year-over-year, from $2.28M to $1.1M.
- What is the long-term trend for Select Medical Holdings's accounts receivable, credit loss expense (reversal)?
- Over 2 years (2022 to 2024), Select Medical Holdings's accounts receivable, credit loss expense (reversal) has grown at a 395.9% compound annual growth rate (CAGR), from $174K to $4.28M.